One of the key factors boosting the market's development and demand is the ease with which surgeons and patients can use this software, owing to technology's quick advancement. Additionally, the growth of the market is being driven by the growing incidence of chronic disorders that call for invasive procedures during the course of the anticipated period.
The market is growing as a result of the aging population, rising surgery volumes, rapid advancements in orthopedic surgery and cloud computing technologies, and growth in the number of senior people. Similar to this, market growth over the anticipated period is being driven by an increase in the frequency of orthopedic ailments and an aging population.
The pre-operative surgery planning software market would expand more quickly and provide a lot of potential opportunities for the market throughout the projected period as patients in emerging countries become more conscious of orthopedic illnesses. A rise in the incidence of auto accidents and sports injuries led to an increase in the demand for joint replacement therapy.
According to the Indian government, a total of 4,12,432 road accidents were registered in the nation in 2021, killing 1,53,972 deaths and injuring 3,84,448 people. Sadly, the age range that is most severely hit by road accidents is 18 to 45 years old, which accounts for almost 67 percent of all unintentional fatalities. Furthermore, China's total number of motor vehicles climbed by 68.12% during the course of ten years, from 207 million in 2010 to 348 million in 2019. As a result, one of the largest public health concerns in the APAC area has been road safety. As a result, more procedures are being performed in the area. The popularity of surgical planning software is anticipated to expand across the area as a consequence of the growing demand for operations and the rising number of injuries from auto accidents.
The China market dominated the Asia Pacific Surgical Planning Software Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $10,263.3 Thousands by 2028. The Japan market is estimated to grow a CAGR of 6.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 8% during (2022 - 2028).
Based on Deployment, the market is segmented into Cloud and On-premise. Based on End Use, the market is segmented into Hospitals and Clinics & Others. Based on Application, the market is segmented into Orthopedic Surgery, Neurosurgery, Dental & Orthodontics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Zimmer Biomet Holdings, Inc., Medtronic plc, Materialise NV, Brainlab AG, 3D Systems Corporation, Renishaw Plc., Johnson & Johnson (DePuy Synthes), Canon, Inc. (Canon Medical Systems Corporation), and General Electric (GE) Co. (GE Healthcare).
Scope of the Study
Market Segments Covered in the Report:
By Deployment
- Cloud
- On-premise
By End Use
- Hospitals
- Clinics & Others
By Application
- Orthopedic Surgery
- Neurosurgery
- Dental & Orthodontics
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Stryker Corporation
- Zimmer Biomet Holdings, Inc
- Medtronic plc
- Materialise NV
- Brainlab AG
- 3D Systems Corporation
- Renishaw Plc
- Johnson & Johnson (DePuy Synthes)
- Canon, Inc. (Canon Medical Systems Corporation)
- General Electric (GE) Co. (GE Healthcare)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Surgical Planning Software Market, by Deployment
1.4.2 Asia Pacific Surgical Planning Software Market, by End Use
1.4.3 Asia Pacific Surgical Planning Software Market, by Application
1.4.4 Asia Pacific Surgical Planning Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2019, Jan - 2022, Sep) Leading Players
Chapter 4. Asia Pacific Surgical Planning Software Market by Deployment
4.1 Asia Pacific Cloud Market by Country
4.2 Asia Pacific On-premise Market by Country
Chapter 5. Asia Pacific Surgical Planning Software Market by End-use
5.1 Asia Pacific Hospitals Market by Country
5.2 Asia Pacific Clinics & Others Market by Country
Chapter 6. Asia Pacific Surgical Planning Software Market by Application
6.1 Asia Pacific Orthopedic Surgery Market by Country
6.2 Asia Pacific Neurosurgery Market by Country
6.3 Asia Pacific Dental & Orthodontics Market by Country
6.4 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Surgical Planning Software Market by Country
7.1 China Surgical Planning Software Market
7.1.1 China Surgical Planning Software Market by Deployment
7.1.2 China Surgical Planning Software Market by End-use
7.1.3 China Surgical Planning Software Market by Application
7.2 Japan Surgical Planning Software Market
7.2.1 Japan Surgical Planning Software Market by Deployment
7.2.2 Japan Surgical Planning Software Market by End-use
7.2.3 Japan Surgical Planning Software Market by Application
7.3 India Surgical Planning Software Market
7.3.1 India Surgical Planning Software Market by Deployment
7.3.2 India Surgical Planning Software Market by End-use
7.3.3 India Surgical Planning Software Market by Application
7.4 South Korea Surgical Planning Software Market
7.4.1 South Korea Surgical Planning Software Market by Deployment
7.4.2 South Korea Surgical Planning Software Market by End-use
7.4.3 South Korea Surgical Planning Software Market by Application
7.5 Singapore Surgical Planning Software Market
7.5.1 Singapore Surgical Planning Software Market by Deployment
7.5.2 Singapore Surgical Planning Software Market by End-use
7.5.3 Singapore Surgical Planning Software Market by Application
7.6 Malaysia Surgical Planning Software Market
7.6.1 Malaysia Surgical Planning Software Market by Deployment
7.6.2 Malaysia Surgical Planning Software Market by End-use
7.6.3 Malaysia Surgical Planning Software Market by Application
7.7 Rest of Asia Pacific Surgical Planning Software Market
7.7.1 Rest of Asia Pacific Surgical Planning Software Market by Deployment
7.7.2 Rest of Asia Pacific Surgical Planning Software Market by End-use
7.7.3 Rest of Asia Pacific Surgical Planning Software Market by Application
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Medtronic PLC
8.2.1 Company overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 3D Systems Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Stryker Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisition and Mergers:
8.5 Zimmer Biomet Holdings, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 Materialise NV
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 Johnson & Johnson (DePuy Synthes)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental &Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.8 Renishaw PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Approvals and Trials:
8.9 Canon, Inc. (Canon Medical Systems Corporation)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. Brainlab AG
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Acquisition and Mergers:
Companies Mentioned
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Medtronic plc
- Materialise NV
- Brainlab AG
- 3D Systems Corporation
- Renishaw Plc.
- Johnson & Johnson (DePuy Synthes)
- Canon, Inc. (Canon Medical Systems Corporation)
- General Electric (GE) Co. (GE Healthcare)
Methodology
LOADING...